ES2064149T3 - Nuevos derivados del indol, procedimiento de preparacion y medicamentos que los contienen. - Google Patents

Nuevos derivados del indol, procedimiento de preparacion y medicamentos que los contienen.

Info

Publication number
ES2064149T3
ES2064149T3 ES92400764T ES92400764T ES2064149T3 ES 2064149 T3 ES2064149 T3 ES 2064149T3 ES 92400764 T ES92400764 T ES 92400764T ES 92400764 T ES92400764 T ES 92400764T ES 2064149 T3 ES2064149 T3 ES 2064149T3
Authority
ES
Spain
Prior art keywords
indol
alkyl
represent
new derivatives
replaced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92400764T
Other languages
English (en)
Inventor
Didier Festal
Denis Descours
Robert Bellemin
Jacques Decerprit
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sante SAS
Original Assignee
LIPHA SAS
LIPHA Liyonnaise Industrielle Pharmaceutique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LIPHA SAS, LIPHA Liyonnaise Industrielle Pharmaceutique filed Critical LIPHA SAS
Application granted granted Critical
Publication of ES2064149T3 publication Critical patent/ES2064149T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Abstract

NUEVOS DERIVADOS DEL INDOL, PROCESO DE PREPARACION Y MEDICAMENTOS QUE LOS CONTIENEN. LA INVENCION SE REFIERE A DERIVADOS DEL INDOL DE FORMULA, EN LA QUE R1 Y R2 REPRESENTAN H, ALQUILO, ALCENILO, CICLOALQUILO, N-ALQUILAMINO LMETILO O FENILO EVENTUALMENTE SUSTITUIDOS, R3 Y R4 REPRESENTAN H, HALOGENO, ALQUILO, ALCOXI, ALQUILTIO, CF3, NO2, N-ALQUILAMINO O N,N-DIALQUILAMINO, BENCILO O FENILO EVENTUALMENTE SUSTITUIDOS, R5 REPRESENTA H, ALQUILO, CICLOALQUILO O BENCILO EVENTUALMENTE SUSTITUIDO. R6 DESIGNA UN RADICAL ALQUILO, FENILO O HETEROCICLICO EVENTUALMENTE SUSTITUIDOS, Z DESIGNA LOS BIRRADICALES: -(CH2)N N=0-2, P=0-2 Y N + P MENOR O IGUAL A 2, R7 Y R8 REPRESENTAN H, ALQUILO, ALCENILO, CICLOALQUILO, N-ALQUILAMINO, N,N-DIALQUILAMINO, N-ALIKILAMINO PUEDEN ESTAR SUSTITUIDOS, O FORMAN JUNTOS CADENAS POLIMETILENA U OXA-, TIA SUS PROCESOS DE PREPARACION Y APLICACION COMO MEDICAMENTOS HIPOLIPIDEMIANTES, ANTIATEROMATOSOS Y ANTIDIABETICOS
ES92400764T 1991-03-26 1992-03-20 Nuevos derivados del indol, procedimiento de preparacion y medicamentos que los contienen. Expired - Lifetime ES2064149T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9103618A FR2674522B1 (fr) 1991-03-26 1991-03-26 Nouveaux derives de l'indole, procedes de preparation et medicaments les contenant.

Publications (1)

Publication Number Publication Date
ES2064149T3 true ES2064149T3 (es) 1995-01-16

Family

ID=9411107

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92400764T Expired - Lifetime ES2064149T3 (es) 1991-03-26 1992-03-20 Nuevos derivados del indol, procedimiento de preparacion y medicamentos que los contienen.

Country Status (25)

Country Link
US (1) US5219859A (es)
EP (1) EP0506532B1 (es)
JP (1) JPH0597802A (es)
KR (1) KR950007753B1 (es)
AT (1) ATE111078T1 (es)
AU (1) AU658609B2 (es)
CA (1) CA2063170A1 (es)
CS (1) CS89592A3 (es)
DE (1) DE69200378T2 (es)
DK (1) DK0506532T3 (es)
ES (1) ES2064149T3 (es)
FR (1) FR2674522B1 (es)
HU (1) HUT65489A (es)
IE (1) IE65366B1 (es)
IL (1) IL101248A (es)
MA (1) MA22474A1 (es)
MX (1) MX9201365A (es)
NO (1) NO178260C (es)
NZ (1) NZ242078A (es)
OA (1) OA09573A (es)
RU (1) RU2074179C1 (es)
SI (1) SI9210305A (es)
TN (1) TNSN92022A1 (es)
YU (1) YU30592A (es)
ZA (1) ZA922163B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2687402B1 (fr) * 1992-02-14 1995-06-30 Lipha Nouveaux azaindoles, procedes de preparation et medicaments les contenant.
JPH07503737A (ja) * 1992-05-28 1995-04-20 フアイザー・インコーポレイテツド アシル補酵素ａ：コレステロールアシルトランスフェラーゼ（ａｃａｔ）の阻害剤としての新規なｎ−アリールおよびｎ−ヘテロアリール尿素誘導体
NZ250916A (en) * 1993-02-27 1995-08-28 Nihon Nohyaku Co Ltd N-heteroaryl-n'-phenylureas, their use as acat inhibitors
IL109568A0 (en) * 1993-05-19 1994-08-26 Fujisawa Pharmaceutical Co Urea derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
DE4401893A1 (de) * 1994-01-24 1995-07-27 Bayer Ag Substituierte Arylharnstoffe
JP3720395B2 (ja) 1994-09-20 2005-11-24 京都薬品工業株式会社 新規ヘテロ環誘導体、その製造方法およびその医薬用途
KR100241643B1 (ko) * 1995-06-06 2000-03-02 디. 제이. 우드 당뇨병치료제인 치환된 N-(인돌-2-카르보닐)-β-알라님아미드 및 그의 유도체
DK0832065T3 (da) * 1995-06-06 2001-11-19 Pfizer Substituerede N-(indol-2-carbonyl)glycinamider og derivater som glycogenphosphorylaseinhibitorer
MX9709874A (es) 1995-06-06 1998-03-31 Pfizer N-(INDOL-2-CARBONIL) beta-ALANILAMIDAS SUSTITUIDAS Y DERIVADOS COMO INHIBIDORES DE GLUCOGENO FOSFORILASA, USO DE LOS MISMOS Y COMPOSICIONES QUE LOS CONTIENEN.
AU679887B2 (en) * 1995-09-11 1997-07-10 Nihon Nohyaku Co., Ltd. Azole derivatives, their use, production and usage
ES2164920T3 (es) * 1995-10-05 2002-03-01 Kyoto Pharma Ind Nuevos derivados heterociclicos y uso medicinal de los mismos.
EP0773218A1 (en) * 1995-11-13 1997-05-14 Mitsubishi Chemical Corporation N-(Piperazinylalkoxyphenyl)-N'phenylalkylurea derivatives as ACAT inhibitors for the treatment of atheroschlerosis
FR2763334A1 (fr) * 1997-05-13 1998-11-20 Lipha Derives anthraniliques
US6545022B1 (en) * 1997-12-16 2003-04-08 Pfizer Inc. 4(3)substituted-4(3)-aminomethyl-(thio)pyran or piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
BR9813656A (pt) * 1997-12-16 2000-10-10 Warner Lambert Co Aminas como agentes farmacêuticos
CN1495160A (zh) * 1997-12-16 2004-05-12 ��ʲ 1-取代-1-氨基甲基-环烷衍生物（＝加巴喷丁类似物）、其制备及其在治疗神经病方面的用途
SK282727B6 (sk) 1997-12-19 2002-11-06 Slovakofarma, A. S. 1,3-Disubstituované močoviny - inhibítory ACAT a spôsob ich prípravy
US6277877B1 (en) 2000-08-15 2001-08-21 Pfizer, Inc. Substituted n-(indole-2-carbonyl)glycinamides and derivates as glycogen phosphorylase inhibitors
US7153882B2 (en) 2000-11-02 2006-12-26 The United States Of America As Represented By The Department Of Health And Human Services Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof
AU2003236247A1 (en) * 2002-05-03 2003-11-17 Warner-Lambert Company Llc Bombesin antagonists
US7429612B2 (en) * 2002-07-17 2008-09-30 Kyoto Pharmaceutical Industries, Ltd. Indoline compound and medicinal use thereof
EP1615900A1 (en) * 2003-04-01 2006-01-18 Eli Lilly And Company Benzisothiazol-3-one-carboxylic acid amides as phospholipase inhibitors
JP2009517430A (ja) 2005-11-30 2009-04-30 エフ．ホフマン−ラ ロシュ アーゲー ３−アミノ−１−アリールプロピルインドール類及びアザ置換インドール類
RU2008120141A (ru) 2005-11-30 2010-01-10 Ф. Хоффманн-Ля Рош Аг (Ch) 3-амино-2-арилпропилазаиндолы и их применения
RU2361581C2 (ru) * 2007-09-14 2009-07-20 Закрытое Акционерное Общество "Мастерклон" Фармацевтическая композиция, обладающая противодиабетической, гиполипидемической, гипогликемической и гипохолестеринемической активностью, способ ее получения и способы лечения указанных заболеваний
SK287385B6 (sk) 2007-11-27 2010-08-09 Hameln-Rds, A. S. 1,3-Disubstituované močoviny, spôsob ich prípravy a použitia
CN104628621A (zh) * 2015-01-22 2015-05-20 湖南华腾制药有限公司 一种氟取代吲哚衍生物的制备方法
CN110913854B (zh) 2017-06-26 2023-04-28 卢内拉生物技术有限公司 mitoketoscin：靶向癌细胞中酮代谢的基于线粒体的治疗剂
MX2021010193A (es) 2019-02-27 2021-09-21 Univ California Azepino-indoles y otros heterociclos para el tratamiento de trastornos cerebrales.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55151505A (en) * 1979-05-14 1980-11-26 Kuraray Co Ltd Indole agricultural and horticultural fungicide
CA1299174C (en) * 1987-02-02 1992-04-21 Michael Edward Flaugh Alkylmelatonins
EP0375133A1 (en) * 1988-11-14 1990-06-27 The Upjohn Company Alpha-amino-indole-3-acetic acids useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents
IL95584A (en) * 1989-09-07 1995-03-15 Abbott Lab Indole-, benzoporene- and benzothiophene compounds including lipoxygenase-inhibiting compounds and pharmaceutical compounds containing them
MX22406A (es) * 1989-09-15 1994-01-31 Pfizer Nuevos derivados de n-aril y n-heteroarilamidas y urea como inhibidores de acil coenzima a: acil transferasa del colesterol (acat).
ATE130002T1 (de) * 1990-08-13 1995-11-15 Hoechst Roussel Pharma 1-(pyridinylalkyl)-1h-indole, -indoline und analoge.
FR2680366B1 (fr) * 1991-08-13 1995-01-20 Adir Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
WO1993005020A1 (en) * 1991-09-06 1993-03-18 Merck & Co., Inc. Indoles as inhibitors of hiv reverse transcriptase

Also Published As

Publication number Publication date
IE920937A1 (en) 1992-10-07
IL101248A0 (en) 1992-11-15
DE69200378T2 (de) 1995-03-09
MX9201365A (es) 1992-10-01
KR920018022A (ko) 1992-10-21
ZA922163B (en) 1993-09-27
SI9210305A (en) 1996-02-29
HUT65489A (en) 1994-06-28
EP0506532B1 (fr) 1994-09-07
FR2674522B1 (fr) 1993-07-16
AU1309492A (en) 1992-10-01
NO178260C (no) 1996-02-21
JPH0597802A (ja) 1993-04-20
NO921141L (no) 1992-09-28
IE65366B1 (en) 1995-10-18
CS89592A3 (en) 1992-10-14
DK0506532T3 (da) 1995-02-20
EP0506532A1 (fr) 1992-09-30
NZ242078A (en) 1994-10-26
US5219859A (en) 1993-06-15
YU30592A (sh) 1994-12-28
IL101248A (en) 1996-12-05
KR950007753B1 (ko) 1995-07-14
HU9200997D0 (en) 1992-05-28
DE69200378D1 (de) 1994-10-13
RU2074179C1 (ru) 1997-02-27
TNSN92022A1 (fr) 1993-06-08
NO921141D0 (no) 1992-03-24
ATE111078T1 (de) 1994-09-15
MA22474A1 (fr) 1992-10-01
OA09573A (fr) 1993-01-31
NO178260B (no) 1995-11-13
FR2674522A1 (fr) 1992-10-02
CA2063170A1 (en) 1992-09-27
AU658609B2 (en) 1995-04-27

Similar Documents

Publication Publication Date Title
ES2064149T3 (es) Nuevos derivados del indol, procedimiento de preparacion y medicamentos que los contienen.
NL971014I2 (nl) Heterocyclische verbindingen.
ES2040276T3 (es) Derivados de la indolizina, procedimiento para su preparacion y composiciones que los contienen.
ES2166379T3 (es) 2-aminotetralinas sustituidas.
ES2021027T5 (es) Un procedimiento para producir un compuesto de piridinsulfonamida sustituido.
FR2456741A1 (fr) Esters, thio-esters et amides d'acides thiaxanthone-carboxyliques, corps intermediaires et procedes servant a les preparer, et leur utilisation comme sensibilisateurs de reticulation ou initiateurs de photopolymerisation
ES2055119T3 (es) Procedimiento para la preparacion de derivados de la bacatina iii y de la desacetil-10 bacatina iii.
DE3881483D1 (de) Photographisches element, das gelbe filterfarbstoffe mit tricyanvinylgruppen enthaelt.
DE3778396D1 (de) 1h-imidazol-5-carbonsaeurederivate.
DK234885A (da) Cephalosporinderivater
FR2558837B1 (fr) Derives de l'acide methylenediphosphonique, procede d'obtention et medicaments antirhumatismaux les contenant
CO4520266A1 (es) Derivado de 1,3-oxazin-4-ona, el herbicida que lo contiene y los productos intermedios para prepararlo
NO880143D0 (no) Soetemiddel.
ES2061530T3 (es) 9-amino-1,4-etano-1,2,3,4-tetrahidroacridina y compuestos afines, intermediarios y un procedimiento para la preparacion de los mismos y su uso como medicamentos.
FI864836A (fi) Kefalosporinfoereningar.
ES8601098A1 (es) Procedimiento para la obtencion de monoesteres de acido tartarico opticamente puros de alcanolaminas opticamente activas
ES2072304T3 (es) Pirazolinas n-sulfeniladas y n-aciladas.
DE3867205D1 (de) Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung.
ES2058557T3 (es) Monoesteres de un acido arilacetico, su produccion y uso.
SE7713968L (sv) Basiskt alkylerade ditiosalicylsyraamider, sett for framstellning derav samt anvendning derav som lekemedel
ES2055690T3 (es) Medicamento antihipoxico.
IT8620798A0 (it) Derivati triazinici di piperidinilammidine atti all'impiego come stabilizzanti per polimeri sintetici.
ES438031A1 (es) Un procedimiento para la preparacion de tetralinas sustitui-das.
DK0850939T3 (da) Ellipticin-derivater, fremgangsmåde til fremstilling deraf og farmaceutiske sammensætninger indeholdende derivaterne
ES2103474T3 (es) Amino-compuestos como estabilizantes de elaboracion para materias sinteticas termoplasticas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 506532

Country of ref document: ES